Clinical Study

Prevalence of Chronic Kidney Disease and Its Related Risk Factors in Elderly of Southern Iran: A Population-Based Study

Table 1

Demographic characteritics of participants with chronic kidney diseases according to their stages.

VariablesCKD stages
0 to II (%)III to V (%)P-valueTotal (%)
( ) ( )( )

Age (mean ± SD) <0.001
Age groups (years)
 60  to 69537 (65.6)204 (55.0)0.002741 (62.3)
 70  to 79231 (28.2)133 (35.8)364 (30.6)
 ≥8051 (6.2)34 (9.2)85 (7.1)
Sex
 Male400 (48.8)81 (21.8)<0.001481 (40.4)
 Female419 (51.2)290 (78.2)709 (59.6)
Occupation
 Governmental17 (2.1)6 (1.6)23 (1.9)
 Housekeeper263 (32.1)204 (55.0)<0.001467 (39.2)
 Farmer109 (13.3)20 (5.4)129 (10.8)
 Self-employed149 (18.2)38 (10.2)187 (15.7)
 Industrial1 (0.1)1 (0.3)2 (0.2)
 Others37 (4.5)37 (10.0)155 (13.1)
 Missing243 (29.7)65 (17.5)227 (19.1)
Education
 Under diploma564 (68.9)279 (75.2)0.05843 (70.9)
 Diploma and associated degree62 (7.6)23 (6.2)85 (7.1)
 Bachelor and higher14 (1.7)1 (0.3)15 (1.3)
 Missing179 (21.8)68 (18.3)247 (20.7)
BMI
 Under 18.523 (2.8)6 (1.6)<0.00129 (2.4)
 18.6 to 25316 (38.6)112 (30.2)428 (36.0)
 Up to 26298 (36.4)184 (49.6)482 (40.5)
 Missing182 (22.2)69 (18.6)251 (21.1)
Hypertension*
 No551 (67.3)187 (50.4)<0.001738 (62.0)
 Yes268 (32.7)184 (49.6)452 (38.0)

CKD classified into 5 stages; stage 0: eGFR >90 mL/min/1.73  , no proteinuria, and normal kidney function; stage 1: eGFR >90 mL/min/1.73  with evidence of kidney damage; stage 2: eGFR 60–89 mL/min/1.73  , mild decrease in GFR; stage 3: eGFR 30–59 mL/min/1.73  , moderate decrease in GFR; stage 4: eGFR 15–29 mL/min/1.73  , severe decrease in GFR; and stage 5: eGFR <15 mL/min/1.73  or in dialysis, kidney failure.
Body mass index was defined as weight (in kilograms) and height (in meters), which was categorized as 3 groups of <18.5 kg/ , 18.5 to 24.9 kg/ , and ≥25 kg/ .
*Hypertension was defined as SBP >130 mmHg, DBP >80mmHg, or those who had a positive history of hypertension and were receiving antihypertensive drugs.